$INSP stock has now risen 28% today, according to our price data from Polygon. There has been approximately $387,293,714 of trading volume.
It has been the 372nd most-searched ticker on Quiver Quantitative over the last day, out of 10,293 total tickers searched.
Here is what we see in our data on $INSP (you can track the company live on Quiver's $INSP stock page):
$INSP Insider Trading Activity
$INSP insiders have traded $INSP stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $INSP stock by insiders over the last 6 months:
- RICHARD BUCHHOLZ (Chief Financial Officer) sold 11,000 shares for an estimated $1,027,290
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$INSP Hedge Fund Activity
We have seen 164 institutional investors add shares of $INSP stock to their portfolio, and 265 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRAGONEER INVESTMENT GROUP, LLC removed 2,354,411 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $174,697,296
- CITADEL ADVISORS LLC added 1,739,734 shares (+20054.6%) to their portfolio in Q3 2025, for an estimated $129,088,262
- FMR LLC removed 1,536,430 shares (-67.2%) from their portfolio in Q3 2025, for an estimated $114,003,106
- WASATCH ADVISORS LP removed 1,498,481 shares (-91.7%) from their portfolio in Q3 2025, for an estimated $111,187,290
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,058,890 shares (+174.1%) to their portfolio in Q3 2025, for an estimated $78,569,638
- DEERFIELD MANAGEMENT COMPANY, L.P. added 907,694 shares (+648.4%) to their portfolio in Q3 2025, for an estimated $67,350,894
- SOLEUS CAPITAL MANAGEMENT, L.P. added 619,188 shares (+568.1%) to their portfolio in Q3 2025, for an estimated $45,943,749
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$INSP Government Contracts
We have seen $3,448,193 of award payments to $INSP over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IMPLANTS: $142,010
- PROSTHETIC ORDER - IMPLANT ITEMS: $75,226
- INSPIRE IMPLANTS: $50,150
- IMPLANT: $50,150
- IMPLANTABLE PULSE GENERATOR: $50,150
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$INSP Analyst Ratings
Wall Street analysts have issued reports on $INSP in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 11/24/2025
- RBC Capital issued a "Outperform" rating on 11/04/2025
- Piper Sandler issued a "Overweight" rating on 11/04/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- UBS issued a "Buy" rating on 08/05/2025
- Morgan Stanley issued a "Overweight" rating on 07/15/2025
To track analyst ratings and price targets for $INSP, check out Quiver Quantitative's $INSP forecast page.
$INSP Price Targets
Multiple analysts have issued price targets for $INSP recently. We have seen 13 analysts offer price targets for $INSP in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Jonathan Block from Stifel set a target price of $110.0 on 11/24/2025
- Larry Biegelsen from Wells Fargo set a target price of $90.0 on 11/04/2025
- Shagun Singh from RBC Capital set a target price of $125.0 on 11/04/2025
- Adam Maeder from Piper Sandler set a target price of $135.0 on 11/04/2025
- Richard Newitter from Truist Securities set a target price of $84.0 on 11/04/2025
- Robbie Marcus from JP Morgan set a target price of $82.0 on 11/04/2025
- Michael Sarcone from Jefferies set a target price of $85.0 on 10/24/2025
You can track data on $INSP on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
